>>44717
i think this may be the source of the outbreak

https://www.pharmiweb.com/press-release/2019-06-14/phoenix-molecular-designs-and-wuxi-sta-reach-drug-supply-milestone-to-support-phase-iib-study-of-pmd-026-for-tnbc

PhoenixMD is headquartered in Vancouver, British Columbia Canada, with U.S. operations in San Diego, Calif.

PhoenixMD's lead program, PMD-026, is the first RSK inhibitor built for the treatment of triple-negative breast cancer (TNBC). The clinical trial supply was undertaken by STA Pharmaceutical (WuXi STA), a subsidiary of WuXi AppTec, and is being used to support IND-enabling toxicology studies and an upcoming Phase I/Ib study in women with breast cancer.